Barrett Elizabeth A. Insider Trades

Insider Trading History

Track insider trading activity for Barrett Elizabeth A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $4.23M 153,195 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3M 153,195 shares
$19.61
$27.60
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$187k 21,500 shares
$8.68
$8.68
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $0 0 shares
Last Trade
Jul 31, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$26k 3,000 shares
$8.68
$8.68
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $2.42M 87,615 shares
Last Trade
Jul 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 87,615 shares
$18.90
$27.60
Allogene Therapeutics
Allogene Therapeutics ALLO
Director
Holding Value $195k 95,400 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 95,400 shares
$1.29
$2.04
Sage Therapeutics
Sage Therapeutics SAGE
Director
Holding Value $187k 21,500 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$146k 21,500 shares
$6.77
$8.68
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $2.66M 96,377 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 96,377 shares
$11.01
$27.60
Allogene Therapeutics
Allogene Therapeutics ALLO
Director
Holding Value $390k 191,082 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$466k 191,082 shares
$2.44
$2.04
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $2.42M 87,615 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.38M 87,615 shares
$15.70
$27.60
Allogene Therapeutics
Allogene Therapeutics ALLO
Director
Holding Value $237k 116,120 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$662k 116,120 shares
$5.70
$2.04
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $3.45M 125,000 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 125,000 shares
$10.39
$27.60
Allogene Therapeutics
Allogene Therapeutics ALLO
Director
Holding Value $145k 71,070 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$684k 71,070 shares
$9.62
$2.04
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $8.51M 308,358 shares
Last Trade
Jan 31, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.1k 8,195 shares
$7.58
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $4.14M 150,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.16M 150,000 shares
$7.72
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $8.23M 298,220 shares
Last Trade
Jan 04, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$430k 46,968 shares
$9.15
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $9.53M 345,188 shares
Last Trade
Jan 03, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 105,689 shares
$9.73
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Jan 03, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.03M 105,689 shares
$9.73
$27.60
Allogene Therapeutics
Allogene Therapeutics ALLO
Director
Holding Value $129k 63,385 shares
Last Trade
Jul 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 63,385 shares
$21.95
$2.04
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $6.64M 240,739 shares
Last Trade
May 19, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$60k 3,425 shares
$17.51
$27.60
UroGen Pharma
UroGen Pharma URGN
Chief Executive Officer
Holding Value $4.14M 150,000 shares
Last Trade
Jan 31, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.39M 380,000 shares
$22.07
$27.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up